Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,485 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00301275 | Assessing Free Immunoglobulin Light Chains in Patients With Myeloma | completed | — | — | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 10, 2006 | clinicaltrials |
| NCT00300521 | Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 40 | Beijing Chao Yang HospitalOTHER | 1 | Mar 9, 2006 | clinicaltrials |
| NCT00073502 | Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer | completed | Phase 2 | 43 | OSI PharmaceuticalsINDUSTRY | 3 | Feb 22, 2006 | clinicaltrials |
| NCT00291369 | Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis | completed | Phase 3 | 456 | Centre Leon BerardOTHER | 1 | Feb 16, 2006 | clinicaltrials |
| NCT00054808 | Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 40 | Genta IncorporatedINDUSTRY | 1 | Feb 8, 2006 | clinicaltrials |
| NCT00045864 | Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma. | completed | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Feb 6, 2006 | clinicaltrials |
| NCT00045877 | Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments | completed | Phase 2 / Phase 3 | — | Chiron CorporationINDUSTRY | 1 | Feb 6, 2006 | clinicaltrials |
| NCT00035022 | Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas | completed | Phase 1 / Phase 2 | 71 | BioCryst PharmaceuticalsINDUSTRY | 1 | Jan 13, 2006 | clinicaltrials |
| NCT00273247 | Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis | completed | Phase 3 | 150 | National Cancer Institute, MilanOTHER | 1 | Jan 9, 2006 | clinicaltrials |
| NCT00144053 | A Phase Ⅲ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer | completed | Phase 3 | 450 | West Japan Thoracic Oncology GroupOTHER | 0 | Jan 6, 2006 | clinicaltrials |
| NCT00148291 | Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 180 | West Japan Thoracic Oncology GroupOTHER | 0 | Jan 6, 2006 | clinicaltrials |
| NCT00219752 | Safety and Efficacy of Imatinib in Chronic Myelogenous Patients Older Than 70 Years | completed | Phase 2 | 30 | Poitiers University HospitalOTHER | 1 | Dec 22, 2005 | clinicaltrials |
| NCT00154700 | Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Dec 20, 2005 | clinicaltrials |
| NCT00149565 | Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma | completed | Phase 3 | 268 | National Health Research Institutes, TaiwanOTHER | 1 | Dec 16, 2005 | clinicaltrials |
| NCT00138827 | Mouth Care Regimes During Radiotherapy | completed | Phase 4 | 50 | St George Hospital, AustraliaOTHER | 1 | Dec 15, 2005 | clinicaltrials |
| NCT00262210 | A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers | completed | Phase 2 | 50 | National Health Research Institutes, TaiwanOTHER | 1 | Dec 6, 2005 | clinicaltrials |
| NCT00260884 | Phase III Study OF the Gastric Surgery on Advanced Stage Gastric Cancer | completed | Phase 3 | 220 | National Health Research Institutes, TaiwanOTHER | 0 | Dec 2, 2005 | clinicaltrials |
| NCT00234182 | Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC | completed | Phase 1 / Phase 2 | 84 | The University of Hong KongOTHER | 0 | Dec 1, 2005 | clinicaltrials |
| NCT00154726 | Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 0 | Nov 22, 2005 | clinicaltrials |
| NCT00154817 | A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 12 | National Taiwan University HospitalOTHER | 0 | Nov 22, 2005 | clinicaltrials |
| NCT00078065 | Xcellerated T CellsTM in Patients With Multiple Myeloma | completed | Phase 2 | 30 | Xcyte TherapiesINDUSTRY | 1 | Nov 11, 2005 | clinicaltrials |
| NCT00094003 | Study of NS-9 in Patients With Liver Metastases | completed | Phase 1 | 20 | NS Pharma, Inc.INDUSTRY | 1 | Nov 11, 2005 | clinicaltrials |
| NCT00231075 | Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV | completed | Phase 2 | 75 | ARCAGY/ GINECO GROUPOTHER | 1 | Nov 3, 2005 | clinicaltrials |
| NCT00245362 | A Phase II Trial of CG 8020 and CG 2505 in Patients With Nonresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | Cell GenesysINDUSTRY | 1 | Oct 28, 2005 | clinicaltrials |
| NCT00130143 | Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities | completed | N/A | 20 | The Dale & Frances Hughes Cancer CenterOTHER | 1 | Sep 27, 2005 | clinicaltrials |
| NCT00220181 | Prospective Study in Pelvic Radiotherapy Patients | completed | — | 100 | Royal Marsden NHS Foundation TrustOTHER | 0 | Sep 22, 2005 | clinicaltrials |
| NCT00222664 | Qidong Hepatitis B Intervention Study | completed | Phase 4 | 80,000 | University of OxfordOTHER | 2 | Sep 22, 2005 | clinicaltrials |
| NCT00208988 | A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening | completed | N/A | 250 | Emory UniversityOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 23 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00212589 | Patients Preference for Oral or i.v. Therapy | completed | Phase 3 | 60 | Odense University HospitalOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00201318 | A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface Antigen | completed | Phase 2 | 50 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 20, 2005 | clinicaltrials |
| NCT00180908 | Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children | completed | Phase 3 | 226 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Sep 16, 2005 | clinicaltrials |
| NCT00188370 | Ultrasound Biomicroscopy - Apoptosis | completed | Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Sep 16, 2005 | clinicaltrials |
| NCT00168740 | Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102) | completed | Phase 3 | 150 | BiogenINDUSTRY | 2 | Sep 15, 2005 | clinicaltrials |
| NCT00175747 | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | completed | Phase 2 / Phase 3 | 120 | University of British ColumbiaOTHER | 1 | Sep 15, 2005 | clinicaltrials |
| NCT00164437 | CD-ROM Intervention for Prostate Cancer Screening | completed | Phase 2 / Phase 3 | 554 | Centers for Disease Control and PreventionFED | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00165061 | Multi-Center Prospective Randomized Trial Comparing Standard Esophagectomy Against Chemo-Radiotherapy for Treatment of Squamous Esophageal Cancer - Early Results From the Chinese University Research Group for Esophageal Cancer (CURE) | completed | Phase 3 | 80 | Chinese University of Hong KongOTHER | 1 | Sep 14, 2005 | clinicaltrials |
| NCT00166972 | Molecular Mechanism of Trophinin in Cancer Invasion and Metastasis | completed | — | 150 | National Taiwan University HospitalOTHER | 0 | Sep 14, 2005 | clinicaltrials |
| NCT00158041 | Subcutaneous Amifostine Safety Study | completed | Phase 4 | 452 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00158691 | Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas | completed | Phase 3 | 296 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00148057 | Diet and Breast Cancer Prevention Trial | completed | Phase 3 | 4,695 | University Health Network, TorontoOTHER | 1 | Sep 7, 2005 | clinicaltrials |
| NCT00148213 | Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma | completed | — | 100 | University Hospital MuensterOTHER | 1 | Sep 7, 2005 | clinicaltrials |
| NCT00144066 | A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer | completed | Phase 3 | 600 | West Japan Thoracic Oncology GroupOTHER | 0 | Sep 2, 2005 | clinicaltrials |
| NCT00140374 | Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer) | completed | Phase 1 / Phase 2 | 36 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140387 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) | completed | Phase 1 / Phase 2 | 20 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140400 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 50 | Cell GenesysINDUSTRY | 0 | Sep 1, 2005 | clinicaltrials |
| NCT00140569 | Randomized Study for Patients With Follicular Lymphoma Needing Treatment | completed | Phase 3 | 400 | Lymphoma Study AssociationOTHER | 2 | Sep 1, 2005 | clinicaltrials |
| NCT00141635 | Implementation of Quality of Life Diagnostics and Therapy | completed | — | 190 | Tumor Center RegensburgOTHER | 1 | Sep 1, 2005 | clinicaltrials |
| NCT00119899 | Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases | completed | Phase 3 | 150 | Radboud University Medical CenterOTHER | 1 | Aug 31, 2005 | clinicaltrials |
| NCT00073385 | Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 225 | Titan PharmaceuticalsINDUSTRY | 3 | Aug 30, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Mar 10, 2006source: clinicaltrials